Atlassian cuts 5% of head count as the software maker focuses on high-priority areas
Many of Atlassian’s rivals have cut their head count in recent months as rates have moved higher to deal with higher prices. But unemployment remains low.
DOJ says at least 1,000 Trump supporters arrested for Jan. 6 Capitol riot
The Justice Department is criminally investigating Donald Trump for actions before and the day of the Jan. 6, 2021, attack on the U.S. Capitol by supporters.
Risky feedback loops are accelerating climate change, scientists warn
A group of international scientists reviewed climate literature to identify 41 climate feedback loops, 27 of which are accelerating global warming.
Fed’s Powell heads to Capitol Hill this week, and he’s going to have his hands full
Federal Reserve Chairman Jerome Powell to appear before Congress with a tall task.
Insana: The Powell Fed is determined that it’s ‘Never Going Back Again’ to zero rates
The Fed does not want to revisit another period, of more recent vintage, in which it was forced to engage in unconventional monetary policies.
These elite dividend payers have yields that can compete with bonds
Treasury yields have ticked higher, but certain top dividend-paying stocks also provide competitive payoffs to investors.
Atheists avoid — for now — Supreme Court review of lawsuit on Florida shooting prayer vigil
The city of Ocala, Florida, had asked the Supreme Court to consider whether a group of atheists had the legal standing to file suit under the Constitution.
FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July
Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval.
A longevity expert who studied people who live to 110 on how humanity and AI will master aging
BioAge is developing treatments to extend healthy lifespan by targeting molecular causes of aging. Its CEO Kristen Fortney started by studying the super-old.
